Recherche et publications

• Daien V, Gillies MC, Nguyen V, Barthelmes D. Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials Ophthalmology. 2017 Mar
• Daien V, Mura F, Martin G, Audo R, Rivière S, Konate A, Morel J, Villain M, Hahne M, Schneider C, Daien C Th17 and regulatory T cells are increased in blood of patients with birdshot chorioretinopathy. Acta Ophthalmol. 2017 Mar
• Daien V, Pérès K, Matharan F,  Nael V, Edjolo A, Bourdel-Marchasson I 1st, Ritchie K, Tzourio C, Delcourt C, Carrière I. Visual Loss and Subsequent Activity Limitations in the Elderly: The French Three-City Cohort . Am J Public Health. 2017 Feb
• Daien V, Barthelmes D, Nguyen V, Campain A, Walton R, Guymer R, Morlet N, Hunyor AP, Essex RW, Arnold JJ, Gillies Two year outcomes og « treat and extend » ingtravitreal therapy using aflibercept preferentially for neovascular age related macular degeneration. MC; Fight Retinal Blindness Study Group. Retina. 2017 Jan 31.
• Daien V, Villain M, Creuzot-Garcher C. Comparison of Recent Studies of Postoperative Endophthalmitis From the Same National Database-Reply. JAMA Ophthalmol. 2016 Dec 29
• Daien V, Granados L, Kawasaki R, Villain M, Ribstein J, Du Cailar G, Mimran A, Fesler P. Retinal vascular caliber associated with cardiac and renal target organ damage in never-treated hypertensive patients. Microcirculation. 2016 Dec 17.
• Gillies MC, Nguyen V, Daien V, Arnold JJ, Morlet N, Barthelmes D. Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study. Ophthalmology. 2016 Dec
• Babeau F, Busetto T, Hamel C, Villain M, Daien V. Adaptive optics: a tool for screening hydroxychloroquine-induced maculopathy? Acta Ophthalmol. 2016 Nov 2.
• Grenier J, Meunier I, Daien V, Baudoin C, Halloy F, Bocquet B, Blanchet C, Delettre C, Esmenjaud E, Roubertie A, Lenaers G, Hamel CP. WFS1 in Optic Neuropathies: Mutation Findings in Nonsyndromic Optic Atrophy and Assessment of Clinical Severity. Ophthalmology. 2016 Sep
• Payerols A, Eliaou C, Trezeguet V, Villain M, Daien V. Accuracy of PlusOptix A09 distance refraction in pediatric myopia and hyperopia. BMC Ophthalmol. 2016 Jun 1
• Daien V, Papinaud L, Gillies MC, Domerg C, Nagot N, Lacombe S, Daures JP, Carriere I, Villain M. Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture. JAMA Ophthalmol. 2016 Jul 1
• Saumet L, Haouy S, Daien V, Hillaire-Buys D, Roessler J, Sirvent N.Isolated unilateral cranial nerve palsy during childhood acute lymphoblastic leukemia treatment: What does it mean? Arch Pediatr. 2016 Apr
• Verhaeghe F, Villain M, Labauge P, Daien V. Orbital Apex Syndrome Secondary to Herpes Zoster Ophthalmicus. J Neuroophthalmol. 2016 Jun
• Daien V, Papinaud L, Domerg C, Lacombe S, Daures JP, Villain M. Incidence and Characteristics of Cystoid Macular Edema after Cataract Surgery. Ophthalmology. 2016 Mar
• Daien V, Le Pape A, Heve D, CarrièreI,Villain M. Incidence and characteristics of cataract surgery in France from 2009 to 2012: a national population study. Ophthalmology. 2015, Apr. epub.
• Chassine T, Bocquet B, Daien V, Avila-Fernandez A, Ayuso C, Collin RW, Corton M, Hejtmancik JF, van den Born LI, Klevering BJ, Riazuddin SA, Sendon N, Lacroux A, Meunier I, Hamel CP. Autosomal recessive retinitis pigmentosa with RP1 mutations is associated with myopia. Br J Ophthalmol. 2015 Apr. epub. 
• Chassine T, Villain M, Hamel CP,Daien V. How can we prevent myopia progression? Eur J Ophthalmol. 2015 Jan. epub. 
• Donnadieu-Rigole H, Daien V, Blanc D, Michau S, Nalpas B, Villain M, Perney P. The prevalence of optic neuropathy in alcoholic patients-a pilot study. Alcohol ClinExp Res. 2014 Jul;38(7):2034-8 
• Daien V, Carrière I, Kawasaki R, Cristol JP, Villain M, Fesler P, Ritchie K, Delcourt C. Associations of malnutrition with retinal vascular caliber in the elderly: the POLA study. IOVS, 2014 May 27;55(7):4042-9, 2014. 
• Daien V, Pérès K, Villain M, Colvez A, Carrière I, Delcourt C. Visual acuity thresholds associated with activity limitations in the elderly. The POLA Study. ActaOphthalmologica. 2014 Jan 
• Daien V, Carrière I, Kawasaki R, Cristol JP, Villain M, Fesler P, Ritchie K, Delcourt C. Retinal vascular caliber is associated with cardiovascular biomarkers of oxidative stress and inflammation: the POLA study. PLOS ONE. 2013; 8: e71089. 
• Daien V, Kawasaki R, Villain M, Ribstein J, du Cailar G, Mimran A, Fesler P. Retinal vascular caliber is associated with renal function in normotensive and never-treated hypertensive subjects. ActaOphthalmologica. 2013 91: e283-8. 
• Daien V, Turpin C, Lignereux F, Belghobsi R, Le Meur G, Lebranchu P, Pechereau A. Determinants of Ocular Deviation in Esotropic Subjects under General Anesthesia. J PediatrOphthalmol Strabismus. 2013 May-Jun;50(3):155-60. 
• Daien V, Allieu S. Congenitalretinalmacrovessel. J Fr Ophtalmol. 2012 Dec;35(10):852-3.
• Daien V, Navarre S, Fesler P, Vergely L, Villain M, Schneider C.Visual acuity outcome and predictive factors after bevacizumab for central retinal vein occlusion. Eur J Ophthalmol. 2012 May 6;22(6):1013-1018. 
• Daien V, Pérès K, Villain M, Colvez A, Delcourt C, Carrière I. Visual impairment, optical correction, and their impact on activity limitations in elderly persons: the POLA study.Arch Intern Med. 2011 Jul 11;171(13):1206-7
• Daien V, MalrieuEliaou C, Rodiere M, Rivier F, Dufier JL, Villain M. Juvenile   xanthogranuloma with bilateral optic neuritis. Br J Ophthalmol. 2011 Sep;95(9):1331-2. 
• Daien V, Rivière S, Konaté A, Arnaud D, Villain M, Schneider C. Acute diplopia; always look for giant cell arteritis. J Fr Ophtalmol. 2009 Oct;32(8):579.e1-5.&nb

ARVO 2015 (Denver, USA)

• Comparison of non-cycloplegic refraction with the PlusOptix A09 distance refraction and cycloplegic refraction. Arnaud Payerols, Claudie Malrieu-Eliaou, Max Villain, Vincent Daien
• Diagnostic performance of retinal nerve fiber and ganglion cell layers in alcoholic optic neuropathy. Stéphanie Michau, Hélène Donnadieu-Rigole, Max Villain, Pascal Perney, Vincent Daien
• Comparison of retinal vascular caliber measured by adaptive optics and from funds photographs software. Granados L, Koch E, Benesty J, Rossant F, Lerme N, Villain M, Daien V, Paques M
• Incidence and characteristics of cataract surgery in France from 2009 to 2012: a national population study. Ophthalmology. 2015, Apr. In Press, Daien V, Le Pape A, Heve D, CarrièreI,Villain M. 

Société Française d'Ophtalmologie 2015 (Paris, France)

• Comparaison entre la réfraction non cycloplégique à distance avec le PlusOptix A09 et la réfraction sous cycloplégique. Arnaud Payerols, Claudie Malrieu-Eliaou, Max Villain, Vincent Daien
• Une ophtalmie sympathique : cas clinique et revue de la littérature. Hyosun Han, Didier Hoa, Max Villain, Vincent Daien
• Amaurose congénitale de Leber avec mottes pigmentaires au fond d'oeil liée à des mutations hétérozygotes composites du gène KCNJ13. Perez-Roustit Sarah, Marquette Virginie, Bocquet Béatrice, Meunier Isabelle, Hamel Christian

Association Francophone de Strabologie et d'Ophtalmologie Pédiatrique 2015 (Paris, France)

• Comparaison entre la réfraction non cycloplégique à distance avec le PlusOptix A09 et la réfraction sous cycloplégique. Arnaud Payerols, Claudie Malrieu-Eliaou, Max Villain, Vincent Daien
• Anomalies de Peters type II, une décision chirurgicale parfois difficile. Michau S, Villain M, Malrieu-Eliaou C, Daien V
• Table ronde : exotropies précoces. Daien V